{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T11:52:49Z","timestamp":1784375569393,"version":"3.55.0"},"reference-count":175,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CIMB"],"abstract":"<jats:p>Fibromyalgia is a chronic disease marked by extensive musculoskeletal pain, persistent fatigue, and cognitive impairments. Despite its high prevalence, the underlying pathological mechanisms of fibromyalgia are still not fully elucidated. Emerging research has identified the endocannabinoid system as an essential factor in modulating pain and other symptoms related to fibromyalgia. The endocannabinoid system plays a key role in many physiological processes such as pain perception, mood regulation, and inflammation. This review provides a powerful analysis of the principal aspects of fibromyalgia and examines the evidence regarding the involvement of the endocannabinoid system in this condition, focusing on its influence on pain modulation. Moreover, the dysregulation of the endocannabinoid system in fibromyalgia patients will be examined, with an assessment of how variations in endocannabinoid levels and receptor activity may contribute to the clinical manifestations of the condition. A better knowledge of this physiological system could lead to the development of novel strategies for managing fibromyalgia.<\/jats:p>","DOI":"10.3390\/cimb47040230","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T03:35:28Z","timestamp":1743132928000},"page":"230","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Role of the Endocannabinoid System in Fibromyalgia"],"prefix":"10.3390","volume":"47","author":[{"given":"Mario","family":"Garc\u00eda-Dom\u00ednguez","sequence":"first","affiliation":[{"name":"Program of Immunology and Immunotherapy, CIMA-Universidad de Navarra, 31008 Pamplona, Spain"},{"name":"Department of Immunology and Immunotherapy, Cl\u00ednica Universidad de Navarra, 31008 Pamplona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41584-020-00506-w","article-title":"Fibromyalgia: An update on clinical characteristics, aetiopathogenesis and treatment","volume":"16","author":"Giorgi","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Cohen-Biton, L., Buskila, D., and Nissanholtz-Gannot, R. (2022). Review of Fibromyalgia (FM) Syndrome Treatments. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph191912106"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/acr.21896","article-title":"Prevalence of fibromyalgia: A population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project","volume":"65","author":"Vincent","year":"2013","journal-title":"Arthritis Care Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s00296-017-3725-2","article-title":"Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis","volume":"37","author":"Heidari","year":"2017","journal-title":"Rheumatol. Int."},{"key":"ref_5","first-page":"32","article-title":"The patient journey of fibromyalgia in Latin America","volume":"20","author":"Messina","year":"2024","journal-title":"Reumatol. Clin. (Engl. Ed.)"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Ruschak, I., Montes\u00f3-Curto, P., Rossell\u00f3, L., Aguilar Mart\u00edn, C., S\u00e1nchez-Montes\u00f3, L., and Toussaint, L. (2023). Fibromyalgia Syndrome Pain in Men and Women: A Scoping Review. Healthcare, 11.","DOI":"10.3389\/fmed.2024.1286729"},{"key":"ref_7","first-page":"1240","article-title":"Environmental factors and fibromyalgia syndrome: A narrative review","volume":"42","author":"Bazzichi","year":"2024","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e1045","DOI":"10.1097\/PR9.0000000000001045","article-title":"Plasma and interstitial levels of endocannabinoids and N-acylethanolamines in patients with chronic widespread pain and fibromyalgia: A systematic review and meta-analysis","volume":"7","author":"Kurlyandchik","year":"2022","journal-title":"Pain Rep."},{"key":"ref_9","first-page":"607","article-title":"Review of the Endocannabinoid System","volume":"6","author":"Lu","year":"2021","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/j.pain.0000000000002268","article-title":"Cannabinoids, the endocannabinoid system, and pain: A review of preclinical studies","volume":"162","author":"Finn","year":"2021","journal-title":"Pain"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Zou, S., and Kumar, U. (2018). Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19030833"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2017.206","article-title":"CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity","volume":"43","author":"Bains","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Hashiesh, H.M., Sharma, C., Goyal, S.N., Sadek, B., Jha, N.K., Kaabi, J.A., and Ojha, S. (2021). A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of \u03b2-caryophyllene, a dietary cannabinoid. Biomed. Pharmacother., 140.","DOI":"10.1016\/j.biopha.2021.111639"},{"key":"ref_14","first-page":"1","article-title":"Endocannabinoids: Synthesis and degradation","volume":"160","year":"2008","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Strand, N.H., Maloney, J., Kraus, M., Wie, C., Turkiewicz, M., Gomez, D.A., Adeleye, O., and Harbell, M.W. (2023). Cannabis for the Treatment of Fibromyalgia: A Systematic Review. Biomedicines, 11.","DOI":"10.3390\/biomedicines11061621"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Hourfane, S., Mechqoq, H., Bekkali, A.Y., Rocha, J.M., and El Aouad, N. (2023). A Comprehensive Review on Cannabis sativa Ethnobotany, Phytochemistry, Molecular Docking and Biological Activities. Plants, 12.","DOI":"10.3390\/plants12061245"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0026-895X(25)09876-1","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Mol. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1017\/S1462399409000957","article-title":"Emerging role of the cannabinoid receptor CB2 in immune regulation: Therapeutic prospects for neuroinflammation","volume":"11","author":"Cabral","year":"2009","journal-title":"Expert. Rev. Mol. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1007\/s00018-016-2300-4","article-title":"The CB2 receptor and its role as a regulator of inflammation","volume":"73","author":"Turcotte","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"17078","DOI":"10.3390\/molecules191117078","article-title":"Endocannabinoids, related compounds and their metabolic routes","volume":"19","author":"Fezza","year":"2014","journal-title":"Molecules"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Simard, M., Archambault, A.S., Lavoie, J.C., Dumais, \u00c9., Di Marzo, V., and Flamand, N. (2022). Biosynthesis and metabolism of endocannabinoids and their congeners from the monoacylglycerol and N-acyl-ethanolamine families. Biochem. Pharmacol., 205.","DOI":"10.1016\/j.bcp.2022.115261"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/s41593-023-01345-0","article-title":"Postsynaptic synucleins mediate endocannabinoid signaling","volume":"26","author":"Albarran","year":"2023","journal-title":"Nat. Neurosci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1126\/science.adk3863","article-title":"Retrograde endocannabinoid signaling at inhibitory synapses in vivo","volume":"383","author":"Dudok","year":"2024","journal-title":"Science"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jcmgh.2022.05.015","article-title":"Role of the Endocannabinoid System in the Regulation of Intestinal Homeostasis","volume":"14","author":"Cuddihey","year":"2022","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Maccarrone, M. (2017). Metabolism of the Endocannabinoid Anandamide: Open Questions after 25 Years. Front. Mol. Neurosci., 10.","DOI":"10.3389\/fnmol.2017.00166"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/bph.12411","article-title":"Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS","volume":"171","author":"Murataeva","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"26465","DOI":"10.1074\/jbc.M604660200","article-title":"Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha\/beta-hydrolase 4 in this pathway","volume":"281","author":"Simon","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Briand-M\u00e9sange, F., Gennero, I., Salles, J., Trudel, S., Dahan, L., Ausseil, J., Payrastre, B., Salles, J.P., and Chap, H. (2024). From Classical to Alternative Pathways of 2-Arachidonoylglycerol Synthesis: AlterAGs at the Crossroad of Endocannabinoid and Lysophospholipid Signaling. Molecules, 29.","DOI":"10.3390\/molecules29153694"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Kuipers, E.N., Kantae, V., Maarse, B.C.E., van den Berg, S.M., van Eenige, R., Nahon, K.J., Reifel-Miller, A., Coskun, T., de Winther, M.P.J., and Lutgens, E. (2019). High Fat Diet Increases Circulating Endocannabinoids Accompanied by Increased Synthesis Enzymes in Adipose Tissue. Front. Physiol., 9.","DOI":"10.3389\/fphys.2018.01913"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/092986607780090829","article-title":"Critical enzymes involved in endocannabinoid metabolism","volume":"14","author":"Basavarajappa","year":"2007","journal-title":"Protein Pept. Lett."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1124\/pr.112.006387","article-title":"Chemical probes of endocannabinoid metabolism","volume":"65","author":"Blankman","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-mediated control of synaptic transmission","volume":"89","author":"Kano","year":"2009","journal-title":"Physiol. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/1073858410397377","article-title":"Endocannabinoids and retrograde modulation of synaptic transmission","volume":"18","author":"Tanimura","year":"2012","journal-title":"Neuroscientist"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.1007\/s12035-016-0313-5","article-title":"Endocannabinoid System: The Direct and Indirect Involvement in the Memory and Learning Processes-a Short Review","volume":"54","author":"Dzik","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/fcp.12008","article-title":"The role of endocannabinoids in pain modulation","volume":"27","author":"Zogopoulos","year":"2013","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Silva-Cruz, A., Carlstr\u00f6m, M., Ribeiro, J.A., and Sebasti\u00e3o, A.M. (2017). Dual Influence of Endocannabinoids on Long-Term Potentiation of Synaptic Transmission. Front. Pharmacol., 8.","DOI":"10.3389\/fphar.2017.00921"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neuropharm.2019.04.020","article-title":"Endocannabinoid long-term depression revealed at medial perforant path excitatory synapses in the dentate gyrus","volume":"153","author":"Puente","year":"2019","journal-title":"Neuropharmacology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.3892\/mmr.2016.5585","article-title":"Endocannabinoid system: Role in depression, reward and pain control (Review)","volume":"14","author":"Huang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/0269881111408958","article-title":"The endocannabinoid system in anxiety, fear memory and habituation","volume":"26","author":"Ruehle","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Cheung, K.A.K., Peiris, H., Wallace, G., Holland, O.J., and Mitchell, M.D. (2019). The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20236079"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/0269881111400652","article-title":"CNS effects of CB2 cannabinoid receptors: Beyond neuro-immuno-cannabinoid activity","volume":"26","author":"Onaivi","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.2174\/092986710790980023","article-title":"CB1 cannabinoid receptors and their associated proteins","volume":"17","author":"Howlett","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Rezende, B., Alencar, A.K.N., de Bem, G.F., Fontes-Dantas, F.L., and Montes, G.C. (2023). Endocannabinoid System: Chemical Characteristics and Biological Activity. Pharmaceuticals, 16.","DOI":"10.3390\/ph16020148"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1054\/plef.2001.0342","article-title":"Molecular biology of cannabinoid receptors","volume":"66","author":"Lutz","year":"2002","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.pbb.2008.05.010","article-title":"Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures\u2014A short review","volume":"90","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Kendall, D.A., and Yudowski, G.A. (2017). Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease. Front. Cell. Neurosci., 10.","DOI":"10.3389\/fncel.2016.00294"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0306-4522(97)00436-3","article-title":"Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system","volume":"83","author":"Tsou","year":"1998","journal-title":"Neuroscience"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/cercor\/bhj136","article-title":"Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: A regional and laminar analysis","volume":"17","author":"Eggan","year":"2007","journal-title":"Cereb. Cortex"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0022-3565(25)21168-5","article-title":"The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord","volume":"279","author":"Pugh","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0006-8993(98)01321-3","article-title":"Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord","volume":"822","author":"Hohmann","year":"1999","journal-title":"Brain Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/clpt.2011.188","article-title":"Cannabinoid-opioid interaction in chronic pain","volume":"90","author":"Abrams","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2264895","DOI":"10.1080\/24740527.2023.2264895","article-title":"Cannabinoid CB1 Receptor Expression and Localization in the Dorsal Horn of Male and Female Rat and Human Spinal Cord","volume":"7","author":"Parnell","year":"2023","journal-title":"Can. J. Pain"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Freundt-Revilla, J., Kegler, K., Baumg\u00e4rtner, W., and Tipold, A. (2017). Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0181064"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2036.2005.02648.x","article-title":"Review article: Endocannabinoids and their receptors in the enteric nervous system","volume":"22","author":"Duncan","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1365-2982.2009.01372.x","article-title":"Cannabinoid signalling in the enteric nervous system","volume":"21","author":"Galligan","year":"2009","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1111\/j.1476-5381.1996.tb15639.x","article-title":"Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves","volume":"118","author":"Ishac","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1073\/pnas.1218573110","article-title":"Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB1 receptor blockade","volume":"110","author":"Bellocchio","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Mendizabal-Zubiaga, J., Melser, S., B\u00e9nard, G., Ramos, A., Reguero, L., Arrabal, S., Elezgarai, I., Gerrikagoitia, I., Suarez, J., and Rodr\u00edguez De Fonseca, F. (2016). Cannabinoid CB1 Receptors Are Localized in Striated Muscle Mitochondria and Regulate Mitochondrial Respiration. Front. Physiol., 7.","DOI":"10.3389\/fphys.2016.00476"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3892\/etm.2016.3036","article-title":"Immunohistochemical analysis of cannabinoid receptor 1 expression in steatotic rat livers","volume":"11","author":"Zduniak","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Pagano Zottola, A.C., Severi, I., Cannich, A., Ciofi, P., Cota, D., Marsicano, G., Giordano, A., and Bellocchio, L. (2022). Expression of Functional Cannabinoid Type-1 (CB1) Receptor in Mitochondria of White Adipocytes. Cells, 11.","DOI":"10.3390\/cells11162582"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.ijcard.2012.05.033","article-title":"CB1 cannabinoid receptor deficiency promotes cardiac remodeling induced by pressure overload in mice","volume":"167","author":"Liao","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/19382014.2020.1849927","article-title":"Cannabinoid receptors are differentially regulated in the pancreatic islets during the early development of metabolic syndrome","volume":"12","author":"Bermeo","year":"2020","journal-title":"Islets"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1073\/pnas.0504187103","article-title":"Peripheral cannabinoid receptor, CB2, regulates bone mass","volume":"103","author":"Ofek","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.2174\/092986710790980005","article-title":"Endocannabinoid binding to the cannabinoid receptors: What is known and what remains unknown","volume":"17","author":"Reggio","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2012.09.020","article-title":"Endocannabinoid signaling and synaptic function","volume":"76","author":"Castillo","year":"2012","journal-title":"Neuron"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Leo, L.M., and Abood, M.E. (2021). CB1 Cannabinoid Receptor Signaling and Biased Signaling. Molecules, 26.","DOI":"10.3390\/molecules26175413"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Sarkar, A., Mitra, A., and Borics, A. (2023). All-Atom Molecular Dynamics Simulations Indicated the Involvement of a Conserved Polar Signaling Channel in the Activation Mechanism of the Type I Cannabinoid Receptor. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24044232"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/jpet.116.232561","article-title":"Functional Selectivity of CB2 Cannabinoid Receptor Ligands at a Canonical and Noncanonical Pathway","volume":"358","author":"Dhopeshwarkar","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e92281","DOI":"10.1172\/jci.insight.92281","article-title":"Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis","volume":"2","author":"Cinar","year":"2017","journal-title":"JCI Insight"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Simard, M., Rakotoarivelo, V., Di Marzo, V., and Flamand, N. (2022). Expression and Functions of the CB2 Receptor in Human Leukocytes. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.826400"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1021\/acsptsci.9b00049","article-title":"Cannabinoid Receptor 2 (CB2) Signals via G-alpha-s and Induces IL-6 and IL-10 Cytokine Secretion in Human Primary Leukocytes","volume":"2","author":"Saroz","year":"2019","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.4049\/jimmunol.172.4.2111","article-title":"Distinct expression profiles of the peripheral cannabinoid receptor in lymphoid tissues depending on receptor activation status","volume":"172","author":"Rayman","year":"2004","journal-title":"J. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Huang, Z., Wang, H., Wang, J., Zhao, M., Sun, N., Sun, F., Shen, J., Zhang, H., Xia, K., and Chen, D. (2016). Cannabinoid receptor subtype 2 (CB2R) agonist, GW405833 reduces agonist-induced Ca2+ oscillations in mouse pancreatic acinar cells. Sci. Rep., 6.","DOI":"10.1038\/srep29757"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"111881","DOI":"10.1016\/j.yexcr.2020.111881","article-title":"The endocannabinoid receptors CB1 and CB2 affect the regenerative potential of adipose tissue MSCs","volume":"389","author":"Ruhl","year":"2020","journal-title":"Exp. Cell. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.lfs.2014.11.027","article-title":"CB2 receptor-mediated effects of pro-inflammatory macrophages influence survival of cardiomyocytes","volume":"138","author":"Heinemann","year":"2015","journal-title":"Life Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.brainresbull.2009.01.011","article-title":"Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans","volume":"79","author":"Schley","year":"2009","journal-title":"Brain Res. Bull."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/fcp.12716","article-title":"Targeting cannabinoid receptor 2 (CB2) limits collagen production-An in vitro study in a primary culture of human fibroblasts","volume":"36","author":"Carvalho","year":"2022","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Ibsen, M.S., Finlay, D.B., Patel, M., Javitch, J.A., Glass, M., and Grimsey, N.L. (2019). Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.00350"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/bs.apha.2017.04.004","article-title":"Cannabinoid Receptor-Related Orphan G Protein-Coupled Receptors","volume":"80","author":"Irving","year":"2017","journal-title":"Adv. Pharmacol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/j.1476-5381.2012.02019.x","article-title":"GPR18 in microglia: Implications for the CNS and endocannabinoid system signalling","volume":"167","author":"McHugh","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s11481-012-9351-6","article-title":"The endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55","volume":"7","author":"Sharir","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"E1469","DOI":"10.1152\/ajpendo.00269.2012","article-title":"Regulation of GPR119 receptor activity with endocannabinoid-like lipids","volume":"303","author":"Syed","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: Beyond CB1 and CB2","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Guerrero-Alba, R., Barrag\u00e1n-Iglesias, P., Gonz\u00e1lez-Hern\u00e1ndez, A., Valdez-Mor\u00e1les, E.E., Granados-Soto, V., Cond\u00e9s-Lara, M., Rodr\u00edguez, M.G., and Marichal-Cancino, B.A. (2019). Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.01496"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nn.2517","article-title":"Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses","volume":"13","author":"Kim","year":"2010","journal-title":"Nat. Neurosci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"830","DOI":"10.5604\/17322693.1213898","article-title":"Metabolism of endocannabinoids","volume":"70","author":"Biernacki","year":"2016","journal-title":"Postepy. Hig. Med. Dosw. (Online)"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1124\/jpet.109.153858","article-title":"Endocannabinoids suppress excitatory synaptic transmission to dorsal raphe serotonin neurons through the activation of presynaptic CB1 receptors","volume":"331","author":"Shen","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/1073858414524632","article-title":"Endocannabinoids in synaptic plasticity and neuroprotection","volume":"21","author":"Xu","year":"2015","journal-title":"Neuroscientist."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Lipina, C., and Hundal, H.S. (2016). Modulation of cellular redox homeostasis by the endocannabinoid system. Open Biol., 6.","DOI":"10.1098\/rsob.150276"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-psych-113011-143739","article-title":"The endocannabinoid system and the brain","volume":"64","author":"Mechoulam","year":"2013","journal-title":"Annu. Rev. Psychol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-3-540-88955-7_8","article-title":"Roles of the endocannabinoid system in learning and memory","volume":"1","author":"Marsicano","year":"2009","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Pinna, G. (2021). Endocannabinoids and Precision Medicine for Mood Disorders and Suicide. Front. Psychiatry, 12.","DOI":"10.3389\/fpsyt.2021.658433"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1089\/can.2016.0009","article-title":"Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes","volume":"1","author":"Russo","year":"2016","journal-title":"Cannabis Cannabinoid. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrn3772","article-title":"Endocannabinoids: A protective receptor pool","volume":"15","author":"Welberg","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Gallelli, C.A., Calcagnini, S., Romano, A., Koczwara, J.B., de Ceglia, M., Dante, D., Villani, R., Giudetti, A.M., Cassano, T., and Gaetani, S. (2018). Modulation of the Oxidative Stress and Lipid Peroxidation by Endocannabinoids and Their Lipid Analogues. Antioxidants, 7.","DOI":"10.3390\/antiox7070093"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Rathod, S.S., Agrawal, Y.O., Nakhate, K.T., Meeran, M.F.N., Ojha, S., and Goyal, S.N. (2023). Neuroinflammation in the Central Nervous System: Exploring the Evolving Influence of Endocannabinoid System. Biomedicines, 11.","DOI":"10.3390\/biomedicines11102642"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"147135","DOI":"10.1016\/j.brainres.2020.147135","article-title":"Endocannabinoid system alterations in Alzheimer\u2019s disease: A systematic review of human studies","volume":"1749","author":"Berry","year":"2020","journal-title":"Brain Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"5519396","DOI":"10.1155\/2024\/5519396","article-title":"Potential Neuroprotective Effect of the Endocannabinoid System on Parkinson\u2019s Disease","volume":"2024","year":"2024","journal-title":"Parkinsons Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/imm.13378","article-title":"Endocannabinoids in immune regulation and immunopathologies","volume":"164","author":"Rahaman","year":"2021","journal-title":"Immunology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s10571-019-00706-3","article-title":"The Systemic Administration of the Chemokine CCL1 Evokes Thermal Analgesia in Mice Through the Activation of the Endocannabinoid System","volume":"39","author":"Aguirre","year":"2019","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/978-3-319-20825-1_14","article-title":"Endocannabinoids and the Cardiovascular System in Health and Disease","volume":"231","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Wiese, B.M., Alvarez Reyes, A., Vanderah, T.W., and Largent-Milnes, T.M. (2023). The endocannabinoid system and breathing. Front. Neurosci., 17.","DOI":"10.3389\/fnins.2023.1126004"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"102242","DOI":"10.1016\/j.ctim.2019.102242","article-title":"Endocannabinoid system in irritable bowel syndrome and cannabis as a therapy","volume":"48","author":"Pandey","year":"2020","journal-title":"Complement. Ther. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"108216","DOI":"10.1016\/j.pharmthera.2022.108216","article-title":"Cannabinoids and the endocannabinoid system in fibromyalgia: A review of preclinical and clinical research","volume":"240","author":"Bourke","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"ref_107","first-page":"198","article-title":"Clinical endocannabinoid deficiency (CECD) revisited: Can this concept explain the therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?","volume":"35","author":"Smith","year":"2014","journal-title":"Neuro Endocrinol. Lett."},{"key":"ref_108","first-page":"CD011694","article-title":"Cannabinoids for fibromyalgia","volume":"7","author":"Walitt","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_109","first-page":"2643","article-title":"Expression of the endocannabinoid receptors in human fascial tissue","volume":"60","author":"Fede","year":"2016","journal-title":"Eur. J. Histochem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1210\/jc.2014-3455","article-title":"Circadian rhythm of circulating levels of the endocannabinoid 2-arachidonoylglycerol","volume":"100","author":"Hanlon","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_111","first-page":"586","article-title":"The endocannabinoid system: An osteopathic perspective","volume":"108","author":"McPartland","year":"2008","journal-title":"J. Am. Osteopath. Assoc."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/37891","article-title":"Anandamide may mediate sleep induction","volume":"389","author":"Mechoulam","year":"1997","journal-title":"Nature"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jbmt.2006.12.004","article-title":"The diagnosis of fibromyalgia in women may be influenced by menstrual cycle phase","volume":"11","author":"Dunnett","year":"2007","journal-title":"J. Bodyw. Mov. Ther."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/jcb.21046","article-title":"Suppression of fibroblast metalloproteinases by ajulemic acid, a nonpsychoactive cannabinoid acid","volume":"100","author":"Johnson","year":"2007","journal-title":"J. Cell. Biochem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.bcp.2004.11.018","article-title":"Effects of cannabinoids on nitric oxide production by chondrocytes and proteoglycan degradation in cartilage","volume":"69","author":"Mbvundula","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"ref_116","first-page":"S89","article-title":"Genome-wide expression profiling in the peripheral blood of patients with fibromyalgia","volume":"34","author":"Jones","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/art.33338","article-title":"Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia","volume":"64","author":"Smith","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"144","DOI":"10.55563\/clinexprheumatol\/bq7x9n","article-title":"A family-based study to identify genetic biomarkers of fibromyalgia: Consideration of patients\u2019 subgroups","volume":"39","author":"Gerra","year":"2021","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41366-023-01428-9","article-title":"Association between the FAAH C385A variant (rs324420) and obesity-related traits: A systematic review","volume":"48","author":"Vizmanos","year":"2024","journal-title":"Int. J. Obes."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Silva, H.H., Tavares, V., Neto, B.V., Cerqueira, F., Medeiros, R., and Silva, M.G. (2023). FAAH rs324420 Polymorphism: Biological Pathways, Impact on Elite Athletic Performance and Insights for Sport Medicine. Genes, 14.","DOI":"10.3390\/genes14101946"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.2147\/JPR.S320863","article-title":"Understanding the Psychological, Physiological, and Genetic Factors Affecting Precision Pain Medicine: A Narrative Review","volume":"14","author":"Chadwick","year":"2021","journal-title":"J. Pain Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.psyneuen.2008.02.009","article-title":"Anandamide and neutrophil function in patients with fibromyalgia","volume":"33","author":"Kaufmann","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1249\/MSS.0000000000002293","article-title":"Increased Anandamide and Decreased Pain and Depression after Exercise in Fibromyalgia","volume":"52","author":"Stensson","year":"2020","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12944-017-0505-7","article-title":"Alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain\u2014A case control study","volume":"16","author":"Stensson","year":"2017","journal-title":"Lipids Health Dis."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jpain.2018.05.008","article-title":"The Relationship of Endocannabinoidome Lipid Mediators with Pain and Psychological Stress in Women with Fibromyalgia: A Case-Control Study","volume":"19","author":"Stensson","year":"2018","journal-title":"J. Pain"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2826.2008.01689.x","article-title":"A saturated N-acylethanolamine other than N-palmitoyl ethanolamine with anti-inflammatory properties: A neglected story","volume":"20","author":"Stecca","year":"2008","journal-title":"J. Neuroendocrinol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pain.2007.03.008","article-title":"Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain","volume":"133","author":"Goicoechea","year":"2007","journal-title":"Pain"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Johnson, B.W., Strand, N.H., Raynak, J.C., Jara, C., Habtegiorgis, K., Hand, B.A., Hong, S., and Maloney, J.A. (2025). Cannabinoids in Chronic Pain Management: A Review of the history, efficacy, applications, and risks. Biomedicines, 13.","DOI":"10.3390\/biomedicines13030530"},{"key":"ref_129","first-page":"100524","article-title":"Effectiveness and safety of cannabis-based products for medical use in patients with fibromyalgia syndrome: A systematic review","volume":"16","author":"Lopera","year":"2024","journal-title":"Explor. Res. Clin. Soc. Pharm."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.mayocp.2024.02.016","article-title":"Is Medical Cannabis a Solution for Controlling Fibromyalgia Symptoms?","volume":"99","author":"David","year":"2024","journal-title":"Mayo Clin. Proc."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Sagy, I., Bar-Lev Schleider, L., Abu-Shakra, M., and Novack, V. (2019). Safety and Efficacy of Medical Cannabis in Fibromyalgia. J. Clin. Med., 8.","DOI":"10.3390\/jcm8060807"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bpa.2020.08.010","article-title":"Cannabis and cannabidiol (CBD) for the treatment of fibromyalgia","volume":"34","author":"Berger","year":"2020","journal-title":"Best. Pract. Res. Clin. Anaesthesiol."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Blebea, N.M., Pricopie, A.I., Vlad, R.A., and Hancu, G. (2024). Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25084204"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev-pharmtox-031122-113758","article-title":"Synthetic Cannabinoids: A Pharmacological and Toxicological Overview","volume":"63","author":"Silva","year":"2023","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s42238-021-00060-6","article-title":"Medical cannabis for the treatment of fibromyalgia syndrome: A retrospective, open-label case series","volume":"3","author":"Mazza","year":"2021","journal-title":"J. Cannabis Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: A preliminary report","volume":"25","author":"Crippa","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Safi, K., Sobieraj, J., B\u0142aszkiewicz, M., \u017by\u0142a, J., Salata, B., and Dzier\u017canowski, T. (2024). Tetrahydrocannabinol and Cannabidiol for Pain Treatment-An Update on the Evidence. Biomedicines, 12.","DOI":"10.3390\/biomedicines12020307"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Fiz, J., Dur\u00e1n, M., Capell\u00e0, D., Carbonell, J., and Farr\u00e9, M. (2011). Cannabis use in patients with fibromyalgia: Effect on symptoms relief and health-related quality of life. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0018440"},{"key":"ref_139","first-page":"7829427","article-title":"The Consumption of Cannabis by Fibromyalgia Patients in Israel","volume":"2018","author":"Habib","year":"2018","journal-title":"Pain Res. Treat."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/j.pain.0000000000001464","article-title":"An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia","volume":"160","author":"Niesters","year":"2019","journal-title":"Pain"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1185\/030079906X112651","article-title":"Delta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief","volume":"22","author":"Schley","year":"2006","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_142","first-page":"13","article-title":"Effect of adding medical cannabis to analgesic treatment in patients with low back pain related to fibromyalgia: An observational cross-over single centre study","volume":"37","author":"Yassin","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_143","first-page":"e17332","article-title":"A Systematic Review of Fibromyalgia and Recent Advancements in Treatment: Is Medicinal Cannabis a New Hope?","volume":"13","author":"Khurshid","year":"2021","journal-title":"Cureus"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"van Dam, C.J., Kramers, C., Schellekens, A., Bouvy, M., van Dorp, E., Kowal, M.A., Olofsen, E., Dahan, A., Niesters, M., and van Velzen, M. (2024). Cannabis combined with oxycodone for pain relief in fibromyalgia pain: A randomized clinical self-titration trial with focus on adverse events. Front. Pain Res., 5.","DOI":"10.3389\/fpain.2024.1497111"},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Giardina, A., Palmieri, R., Ponticelli, M., Antonelli, C., Carlucci, V., Colangelo, M., Benedetto, N., Di Fazio, A., and Milella, L. (2024). Is a Low Dosage of Medical Cannabis Effective for Treating Pain Related to Fibromyalgia? A Pilot Study and Systematic Review. J. Clin. Med., 13.","DOI":"10.3390\/jcm13144088"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Sridharan, S., Erridge, S., Holvey, C., Coomber, R., Holden, W., Rucker, J.J., Platt, M., and Sodergren, M.H. (2024). Comparison of Cannabis-Based Medicinal Product Formulations for Fibromyalgia: A Cohort Study. J. Pain Palliat. Care. Pharmacother., 1\u201314.","DOI":"10.1080\/15360288.2024.2414073"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jpain.2007.09.002","article-title":"Nabilone for the treatment of pain in fibromyalgia","volume":"9","author":"Skrabek","year":"2008","journal-title":"J. Pain"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1213\/ANE.0b013e3181c76f70","article-title":"The effects of nabilone on sleep in fibromyalgia: Results of a randomized controlled trial","volume":"110","author":"Ware","year":"2010","journal-title":"Anesth. Analg."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1097\/j.pain.0000000000001293","article-title":"Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: A systematic review and meta-analysis of controlled and observational studies","volume":"159","author":"Stockings","year":"2018","journal-title":"Pain"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/phar.1709","article-title":"Nabilone for the Management of Pain","volume":"36","author":"Tsang","year":"2016","journal-title":"Pharmacotherapy"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"18625","DOI":"10.1074\/jbc.M702538200","article-title":"Ajulemic acid, a synthetic nonpsychoactive cannabinoid acid, bound to the ligand binding domain of the human peroxisome proliferator-activated receptor gamma","volume":"282","author":"Ambrosio","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/j.bmc.2014.04.062","article-title":"Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity","volume":"22","author":"Tepper","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"e00394","DOI":"10.1002\/prp2.394","article-title":"Ajulemic acid: Potential treatment for chronic inflammation","volume":"6","author":"Burstein","year":"2018","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000481089","article-title":"Dronabinol Is a Safe Long-Term Treatment Option for Neuropathic Pain Patients","volume":"78","author":"Schimrigk","year":"2017","journal-title":"Eur. Neurol."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Kitdumrongthum, S., and Trachootham, D. (2023). An Individuality of Response to Cannabinoids: Challenges in Safety and Efficacy of Cannabis Products. Molecules, 28.","DOI":"10.3390\/molecules28062791"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/jncimonographs\/lgab009","article-title":"Challenges for Clinical Cannabis and Cannabinoid Research in the United States","volume":"2021","author":"Cooper","year":"2021","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"100009","DOI":"10.1016\/j.pecinn.2021.100009","article-title":"The impact of education on attitudes toward medical cannabis","volume":"1","author":"Clobes","year":"2021","journal-title":"PEC Innov."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Shi, Y., and Wu, W. (2023). Multimodal non-invasive non-pharmacological therapies for chronic pain: Mechanisms and progress. BMC Med., 21.","DOI":"10.1186\/s12916-023-03076-2"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejim.2018.01.016","article-title":"Ethical issues in medical cannabis use","volume":"49","author":"Sagy","year":"2018","journal-title":"Eur. J. Intern. Med."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev-clinpsy-032816-045128","article-title":"Medical Marijuana and Marijuana Legalization","volume":"13","author":"Pacula","year":"2017","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.yebeh.2016.11.011","article-title":"Social factors in marijuana use for medical and recreational purposes","volume":"70","author":"Szaflarski","year":"2017","journal-title":"Epilepsy Behav."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/wps.20735","article-title":"Assessing the public health impacts of legalizing recreational cannabis use: The US experience","volume":"19","author":"Hall","year":"2020","journal-title":"World Psychiatry"},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Morris, M., Chye, R., Liu, Z., Agar, M., and Razmovski-Naumovski, V. (2023). A Retrospective Medical Record Review of Adults with Non-Cancer Diagnoses Prescribed Medicinal Cannabis. J. Clin. Med., 12.","DOI":"10.3390\/jcm12041483"},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Philpot, L.M., Ebbert, J.O., and Hurt, R.T. (2019). A survey of the attitudes, beliefs and knowledge about medical cannabis among primary care providers. BMC Fam. Pract., 20.","DOI":"10.1186\/s12875-019-0906-y"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"101094","DOI":"10.1016\/j.imr.2024.101094","article-title":"Medical cannabis: From research breakthroughs to shifting public perceptions and ensuring safe use","volume":"13","author":"Hossain","year":"2024","journal-title":"Integr. Med. Res."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Li, T., Wang, G.S., Brooks-Russell, A., Tung, G., Leslie, L., Rittiphairoj, T., Oberste, J.P., Yim, T.W., Bero, L., and Samet, J.M. (2024). Methodological challenges and actionable recommendations in studying the health effects of high-concentration THC products. Am. J. Epidemiol., kwae421.","DOI":"10.1093\/aje\/kwae421"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/17470161231164530","article-title":"Cannabis, research ethics, and a duty of care","volume":"19","author":"Wheeldon","year":"2023","journal-title":"Res. Ethics"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1186\/s13063-020-04862-6","article-title":"Clinical trials with cannabis medicines\u2014Guidance for ethics committees, governance officers and researchers to streamline ethics applications and ensuring patient safety: Considerations from the Australian experience","volume":"21","author":"Martin","year":"2021","journal-title":"Trials"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/cpt.1381","article-title":"Positive and Negative Effects of Cannabis and Cannabinoids on Health","volume":"105","author":"Cohen","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.japh.2023.05.014","article-title":"Changes in Arkansans\u2019 attitudes toward pharmacist involvement and regulation of medical cannabis following its availability in Arkansas","volume":"63","author":"Hernandez","year":"2003","journal-title":"J. Am. Pharm. Assoc."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s40801-024-00451-0","article-title":"Older Adults\u2019 Use of Cannabis and Attitudes Around Disclosing Medical Cannabis Use to Their Healthcare Providers in California: A Mixed Methods Study","volume":"11","author":"Narasimhan","year":"2024","journal-title":"Drugs Real World Outcomes"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11916-023-01101-w","article-title":"Medical Cannabis for Chronic Nonmalignant Pain Management","volume":"27","author":"Hameed","year":"2023","journal-title":"Curr. Pain Headache Rep."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Simiyu, D.C., Jang, J.H., and Lee, O.R. (2022). Understanding Cannabis sativa L.: Current Status of Propagation, Use, Legalization, and Haploid-Inducer-Mediated Genetic Engineering. Plants, 11.","DOI":"10.3390\/plants11091236"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-021-00247-4","article-title":"Cannabis use and cannabis use disorder","volume":"7","author":"Connor","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1111\/add.16274","article-title":"The implementation and public health impacts of cannabis legalization in Canada: A systematic review","volume":"118","author":"Hall","year":"2023","journal-title":"Addiction"}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/47\/4\/230\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:03:01Z","timestamp":1760029381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/47\/4\/230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":175,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["cimb47040230"],"URL":"https:\/\/doi.org\/10.3390\/cimb47040230","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]}}}